ArticleThe FEBS journal2025
N-terminal helix formation and dimer-monomer transition of FGF10 in specific recognition of FGFR2b.
Article in The FEBS journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Frameshift Mutations in Exon 1 ofJournal of developmental biology · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Fibroblast growth factors (FGFs) are crucial for various cellular functions, including proliferation, differentiation, tissue repair, and immune responses. FGF10, part of the FGF7 subfamily, binds to the FGFR2b receptor via heparin sulfate. We determined the crystal structure of human FGF10 alone. In the FGFR2b-bound form, the N-terminal region of FGF10 formed an α1 helix. This α1 helix, however, exists as a flexible loop with dual conformations in the unbound structure. Deleting this conformationally dynamic α1 helix reduces cell proliferation activity in vitro. Receptor-binding-induced formation of the α1 helix in FGF10 creates a distinct protruded knob and concave pocket on the globular core of FGFs, increasing the FGFR2b-binding surface by 37%. Size-exclusion chromatography showed a concentration-dependent dimer-monomer shift in purified FGF10, with the hydrophobic dimer interface aligning with the FGFR2b D2-domain-binding surface. These findings suggest that the conformational change in the N-terminal region and the dimer-monomer shift are critical for FGF10's specific binding to FGFR2b, highlighting the functional significance of these structural adaptations.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.